Trial intelligence / Profile preview

Effect of papaverine injection site on cavernosal artery velocity in penile Doppler

IRCT201009284341N2Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of papaverine in sexual dysfunction, sponsored by Iran University of Medical Sciences. Primary endpoint: Cavernosal artery blood flow velocity. Started Sep 2010; status: completed.

02

Drugs

papaverine
03

Conditions

sexual dysfunction

Beyond the preview

Go deeper on IRCT201009284341N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201009284341N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call